Shah H, Jang H, Singh P, Kosti J, et al. Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents. Leuk Lymphoma 2021 Nov 15:1-8. doi: 10.1080/10428194.2021.2002322.
PMID: 34781825